Press Release The Bancorp, Inc. Sets Third Quarter 2023 Financial Results Release Date and Conference Call 13 October 2023
Press Release Boundless Bio Presents Preclinical Data on the Discovery of its Second ecDNA-Directed Therapeutic Candidate, BBI-825, at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 13 October 2023
Press Release Franklin Templeton Closed-End Funds Announce Share Repurchases for the Third Quarter of 2023 13 October 2023
Press Release Marti Reports 2023 First Half Results; Investing in Scaling Ride-Hailing 13 October 2023
Press Release Data From Incyte’s Povorcitinib Clinical Program to Be Featured at the 8th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) 13 October 2023
Press Release Scorpion Therapeutics Presents Preclinical Data for STX-241, a Fourth-Generation EGFR Inhibitor, at the AACR-NCI-EORTC Symposium 2023 13 October 2023
Press Release Power Integrations to Release Third-Quarter Financial Results on November 7 13 October 2023
Press Release Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ≥1) 13 October 2023
Press Release Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process 13 October 2023
